TURNER INVESTMENTS LLC - ACHILLION PHARMACEUTICALS IN ownership

ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 132 filers reported holding ACHILLION PHARMACEUTICALS IN in Q1 2017. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
TURNER INVESTMENTS LLC ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2017$261,000
-5.1%
56,920
-13.0%
0.17%
-3.9%
Q1 2017$275,000
-20.5%
65,420
-21.8%
0.18%
+27.9%
Q4 2016$346,000
-95.6%
83,680
-91.3%
0.14%
-94.6%
Q3 2016$7,798,000
+16.8%
962,810
+12.5%
2.58%
+23.3%
Q2 2016$6,674,000
+0.6%
855,570
-0.5%
2.09%
+16.4%
Q1 2016$6,636,000
-32.5%
859,560
-5.6%
1.80%
-11.6%
Q4 2015$9,830,000
+31.0%
911,010
-16.1%
2.03%
+34.0%
Q3 2015$7,504,000
+53.4%
1,086,000
+96.8%
1.52%
+69.6%
Q2 2015$4,891,000
+1113.6%
551,960
+1576.2%
0.90%
+1764.6%
Q4 2014$403,00032,9300.05%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q1 2017
NameSharesValueWeighting ↓
MAK CAPITAL ONE LLC 5,191,600$8,255,0004.47%
RTW INVESTMENTS, LP 13,749,383$21,862,0002.04%
ARMISTICE CAPITAL, LLC 4,300,000$6,837,0000.52%
DAFNA Capital Management LLC 630,182$1,002,0000.50%
Rock Springs Capital Management LP 2,325,000$3,697,0000.18%
683 Capital Management, LLC 1,000,000$1,590,0000.10%
Alambic Investment Management, L.P. 133,698$213,0000.09%
South Dakota Investment Council 3,037,004$7,310,0000.08%
Alpine Global Management, LLC 205,172$326,0000.08%
Rhenman & Partners Asset Management AB 402,800$640,0000.07%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders